Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Thrombosis (BASKET).php on line 2
Thrombosis (BASKET)
LE WE PMID CA
Thrombosis (BASKET)2719Thrombose (allg)

Anticoagulants

Antiphospholipid syndrome

Atherosclerosis (BASKET)

Atherosclerosis (peripheral vessels)

Autoantibodies Anti Phospholipid Anti Cardiolipin Anti beta 2 GP

Blood coagulation

Blood vessles (Vascular access)

CD36 FAT fatty acid translocase

D Dimers

Fibronectin

Galectin

Homocysteine

Leg (Sonography)

Lipoprotein (HDL)

MTHFR

Nanomedicine

Neoplasia (Cancer survivor)

P selectin

Platelets (BASKET)

Pregnancy (Diseases)

PROS1

Protein Z

Pulmonary embolism

Radiopharmacology

Statin

Thrombolysis

Thrombophilia

Thrombosis (BASKET)

Thrombosis (Postthrombotic syndrome)

Thrombosis (Prophylaxis)

Thrombosis (Thrombophlebitis)

Tissue factor

Vena cava (Diseases)

2006  
1
2003  
2
Diagnosis, investigation, and management of deep vein thrombosis.
[12775619] BMJ 326(7400): 1180-4 (2003)
2002  
3
Venous thromboembolism: pathophysiology, clinical features, and prevention.
[12386044] BMJ 325(7369): 887-90 (2002)
2000  
4
ABC of arterial and venous disease. Swollen lower limb-1: general assessment and deep vein thrombosis.
[10827054] BMJ 320(7247): 1453-6 (2000)
1996  
5
Integrated management of venous thromboembolism.
[8545687] South Med J 89(1): 20-6 (1996)
2006  
6
The aetiology of deep venous thrombosis.
[16905749] QJM 99(9): 581-93 (2006)
2006  
7
How should we diagnose suspected deep-vein thrombosis?
[16728440] QJM 99(6): 377-88 (2006)
2010  
8
2003  
9
Management of venous thromboembolism: past, present, and future.
[12695266] Arch Intern Med 163(7): 759-68 (2003)
1998  
10
The clinical diagnosis of deep venous thrombosis: integrating incidence, risk factors, and symptoms and signs.
[9827782] Arch Intern Med 158(21): 2315-23 (1998)
2007  
11
Travel and venous thrombosis: a systematic review.
[18028182] J Intern Med 262(6): 615-34 (2007)
2006  
12
Effectiveness of written guidelines on the appropriateness of thromboprophylaxis prescriptions for medical patients: a prospective randomized study.
[16961674] J Intern Med 260(4): 369-76 (2006)
2005  
13
Local and systemic thrombolytic therapy for acute deep venous thrombosis.
[15813419] Neth J Med 63(3): 81-90 (2005)
2005  
14
Treatment of deep vein thrombosis: what factors determine appropriate treatment?
[15751565] Can Fam Physician 51(-): 217-23 (2005)
1996  
15
Diagnosis of deep vein thrombosis.
[8616289] Can Fam Physician 42(-): 497-503 (1996)
2008  
16
The treatment of deep vein thrombosis in the pelvis and leg.
[19578455] Dtsch Arztebl Int 105(1-2): 25-33; quiz 33-4 (2008)
2008  
17
Systematic review of emergency physician-performed ultrasonography for lower-extremity deep vein thrombosis.
[18616433] Acad Emerg Med 15(6): 493-8 (2008)
1997  
18
Color Doppler ultrasonography by emergency physicians for the diagnosis of acute deep venous thrombosis.
[9043540] Acad Emerg Med 4(2): 129-32 (1997)
2000  
19
2006  
20
Management of venous thromboembolism.
[16766793] Can J Anaesth 53(6 Suppl): S80-8 (2006)
2006  
21
Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis.
[16766792] Can J Anaesth 53(6 Suppl): S68-79 (2006)
2007  
22
Acute venous disease: venous thrombosis and venous trauma.
[18068560] J Vasc Surg 46 Suppl S(-): 25S-53S (2007)
2009  
23
The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.
[19707288] Vasc Health Risk Manag 5(-): 693-704 (2009)
2006  
24
Management of cancer-associated venous thrombosis.
[17323588] Vasc Health Risk Manag 2(4): 351-6 (2006)
2008  
25
Evaluation of the Management of Acute Venous Thromboembolism and Its Outcomes: One Institution's Experience.
[19749995] P T 33(2): 107-17 (2008)
2009  
26
Thrombophilia testing in people with venous thromboembolism: systematic review and cost-effectiveness analysis.
[19080721] Health Technol Assess 13(2): iii, ix-x, 1-91 (2009)
2006  
27
Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis.
[16707072] Health Technol Assess 10(15): 1-168, iii-iv (2006)
2006  
28
Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study.
[16595080] Health Technol Assess 10(11): 1-110 (2006)
2005  
29
Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis.
[16336844] Health Technol Assess 9(49): iii-iv, ix-x, 1-78 (2005)
2001  
30
Deep venous thrombosis associated with corporate air travel.
[11468114] J Travel Med 8(3): 127-32 (2001)
2008  
31
Triggers, targets and treatments for thrombosis.
[18288180] Nature 451(7181): 914-8 (2008)
1981  
32
2005  
33
A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.
[15729062] Ann Surg 241(3): 397-415 (2005)
1988  
34
Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.
[2456748] Ann Surg 208(2): 227-40 (1988)
2005  
35
Deep vein thrombosis in cancer: the scale of the problem and approaches to management.
[15802275] Ann Oncol 16(5): 696-701 (2005)
2008  
36
Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review.
[18720360] Cancer 113(7): 1685-94 (2008)
2008  
37
Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis.
[18404702] Cancer 112(11): 2483-92 (2008)
2007  
38
A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.
[17634948] Cancer 110(5): 1149-61 (2007)
2003  
39
Venous thrombosis in cancer patients: insights from the FRONTLINE survey.
[12897335] Oncologist 8(4): 381-8 (2003)
2006  
40
Duration of vitamin K antagonist therapy for venous thromboembolism: a systematic review of the literature.
[16838335] Am J Hematol 81(9): 684-91 (2006)
2003  
41
Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.
[12508268] Am J Hematol 72(1): 43-52 (2003)
2008  
42
Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.
[18782432] Thromb J 6(-): 13 (2008)
2008  
43
[Diagnosis and treatment of venous thrombosis].
[19132168] Hamostaseologie 28(5): 376-86 (2008)
2005  
44
[Diagnosis and treatment of venous thrombosis].
[16395485] Hamostaseologie 25(4): 356-66 (2005)
2010  
45
Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review.
[20141579] J Thromb Haemost 8(4): 684-92 (2010)
2010  
46
Reduction in deep vein thrombosis incidence in intensive care after a clinician education program.
[19874469] J Thromb Haemost 8(1): 121-8 (2010)
2009  
47
Prevention of venous thromboembolism: a key patient safety priority.
[19630756] J Thromb Haemost 7 Suppl 1(-): 1-8 (2009)
2008  
48
Current perspective of venous thrombosis in the upper extremity.
[18485082] J Thromb Haemost 6(8): 1262-6 (2008)
2008  
49
D-Dimer for venous thromboembolism diagnosis: 20 years later.
[18419743] J Thromb Haemost 6(7): 1059-71 (2008)
2008  
50
Venous thromboembolic events and organ-specific occult cancers: a review and meta-analysis.
[18284604] J Thromb Haemost 6(5): 781-8 (2008)
2008  
51
Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis.
[18031292] J Thromb Haemost 6(3): 405-14 (2008)
2007  
52
Integrated strategies for the diagnosis of venous thromboembolism.
[17635707] J Thromb Haemost 5 Suppl 1(-): 41-50 (2007)
2007  
53
Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review.
[17155963] J Thromb Haemost 5(2): 296-304 (2007)
2007  
54
Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?
[17059417] J Thromb Haemost 5(1): 5-11 (2007)
2006  
55
Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: yes.
[17026645] J Thromb Haemost 4(12): 2527-9 (2006)
2006  
56
Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet.
[17010151] J Thromb Haemost 4(12): 2530-2 (2006)
2006  
57
More on: incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational, and cross-sectional study in Brazil.
[16981888] J Thromb Haemost 4(12): 2737-8 (2006)
2006  
58
Why should statins prevent venous thromboembolism? A systematic literature search and a call for action.
[16961599] J Thromb Haemost 4(9): 1925-7 (2006)
2006  
59
When to measure factors VIII:C and XI after an acute venous thromboembolic event?
[16839369] J Thromb Haemost 4(7): 1631-2 (2006)
2006  
60
Aspirin in the prevention and treatment of venous thromboembolism.
[16839339] J Thromb Haemost 4(7): 1470-5 (2006)
2006  
61
Incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational and cross-sectional study in Brazil.
[16706970] J Thromb Haemost 4(6): 1266-70 (2006)
2006  
62
Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy: a systematic review.
[16405518] J Thromb Haemost 4(3): 496-500 (2006)
2005  
63
Management studies using a combination of D-dimer test result and clinical probability to rule out venous thromboembolism: a systematic review.
[16150049] J Thromb Haemost 3(11): 2465-70 (2005)
2005  
64
Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists.
[15748236] J Thromb Haemost 3(3): 473-81 (2005)
2005  
65
Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies.
[15670035] J Thromb Haemost 3(2): 292-9 (2005)
2004  
66
Correlation between thrombus regression and recurrent venous thromboembolism. Examining venographic and clinical effects of low-molecular-weight heparins: a meta-analysis.
[15333034] J Thromb Haemost 2(9): 1581-7 (2004)
2004  
67
The role of collagen in thrombosis and hemostasis.
[15102010] J Thromb Haemost 2(4): 561-73 (2004)
2003  
68
Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.
[12941030] J Thromb Haemost 1(9): 1906-13 (2003)
2003  
69
The utility of pretest probability assessment in patients with clinically suspected venous thromboembolism.
[12941028] J Thromb Haemost 1(9): 1888-96 (2003)
2003  
70
Current status and implications of autoimmune antiphospholipid antibodies in relation to thrombotic disease.
[12871358] J Thromb Haemost 1(5): 931-42 (2003)
1999  
71
The diagnostic approach to acute venous thromboembolism. Clinical practice guideline. American Thoracic Society.
[10471639] Am J Respir Crit Care Med 160(3): 1043-66 (1999)
1999  
72
2008  
73
In the clinic. Deep venous thrombosis.
[18765697] Ann Intern Med 149(5): ITC3-1 (2008)
2007  
74
Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.
[17371890] Ann Intern Med 146(6): 454-8 (2007)
2007  
75
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
[17261857] Ann Intern Med 146(3): 204-10 (2007)
2007  
76
Management of venous thromboembolism: a systematic review for a practice guideline.
[17261856] Ann Intern Med 146(3): 211-22 (2007)
2006  
77
Trials that matter: can patients with venous thromboembolism be treated with fixed-dose subcutaneous unfractionated heparin?
[17179061] Ann Intern Med 145(12): 929-31 (2006)
2005  
78
Meta-analysis: The value of clinical assessment in the diagnosis of deep venous thrombosis.
[16027455] Ann Intern Med 143(2): 129-39 (2005)
1999  
79
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
[10366369] Ann Intern Med 130(10): 800-9 (1999)
1999  
80
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.
[10366368] Ann Intern Med 130(10): 789-99 (1999)
1998  
81
Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative.
[9537941] Ann Intern Med 128(8): 663-77 (1998)
2008  
82
Mechanisms of venous thrombosis and resolution.
[18296594] Arterioscler Thromb Vasc Biol 28(3): 387-91 (2008)
2008  
83
New anticoagulants for treatment of venous thromboembolism.
[18296593] Arterioscler Thromb Vasc Biol 28(3): 380-6 (2008)
2002  
84
How we diagnose and treat deep vein thrombosis.
[11964271] Blood 99(9): 3102-10 (2002)
1970  
85
Local and systemic factors in the pathogenesis of thrombosis.
[4916095] Calif Med 112(3): 31-40 (1970)
2008  
86
Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574272] Chest 133(6 Suppl): 454S-545S (2008)
2008  
87
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
[18574271] Chest 133(6 Suppl): 381S-453S (2008)
2004  
88
Role of computed tomography and magnetic resonance imaging for deep venous thrombosis and pulmonary embolism.
[15051664] Circulation 109(12 Suppl 1): I15-21 (2004)
2004  
89
Ultrasonography and diagnosis of venous thromboembolism.
[15051663] Circulation 109(12 Suppl 1): I9-14 (2004)
2004  
90
Laboratory markers in the diagnosis of venous thromboembolism.
[15051662] Circulation 109(12 Suppl 1): I4-8 (2004)
2008  
91
Duration of anticoagulation therapy for venous thromboembolism.
[19074092] Hematology Am Soc Hematol Educ Program -(-): 252-8 (2008)
2006  
92
2004  
93
2009  
94
Venous thromboembolism: the intricacies.
[19242082] J Postgrad Med 55(1): 55-64 (2009)
2009  
95
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review.
[19531787] JAMA 301(23): 2472-85 (2009)
2005  
96
Duration of anticoagulation following venous thromboembolism: a meta-analysis.
[16091573] JAMA 294(6): 706-15 (2005)
2006  
97
Prevention of venous thromboembolism in medically ill patients: a clinical update.
[17148703] Postgrad Med J 82(974): 806-9 (2006)
2005  
98
Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis.
[16202135] BMC Med Imaging 5(-): 6 (2005)
1999  
99
Imaging of the "active" thrombus: can it be a new gold standard for acute deep vein thrombosis?
[10616883] J Nucl Med 40(12): 2036-7 (1999)
1994  
100
Thrombus-specific imaging: approaching the elusive goal.
[8294984] J Nucl Med 35(2): 202-3 (1994)
1991  
101
Lymphoscintigraphic abnormalities in venous thrombosis.
[1941152] J Nucl Med 32(11): 2144-8 (1991)
2008  
102
Use of US in the evaluation of patients with symptoms of deep venous thrombosis of the lower extremities.
[18936036] Radiographics 28(6): 1785-97 (2008)
2006  
103
Diagnosis and treatment of deep-vein thrombosis.
[17060659] CMAJ 175(9): 1087-92 (2006)
1998  
104
Radiological management of venous thrombosis of the lower limb.
[9659126] Br J Radiol 71(844): 353-6 (1998)
1999  
105
Deep venous thrombosis: recent advances and optimal investigation with US.
[10189448] Radiology 211(1): 9-24 (1999)
1985  
106
Deep vein thrombosis: significant limitations of noninvasive tests.
[4001421] Radiology 156(1): 47-9 (1985)
2007  
107
In vivo thrombus formation in murine models.
[17431199] Circ Res 100(7): 979-91 (2007)
2010  
108
Venous thromboembolism in cancer patients: ESMO Clinical Practice Guidelines for the management.
[20555096] Ann Oncol 21 Suppl 5(-): v274-6 (2010)
2009  
109
Management of venous thromboembolism in cancer patients: ESMO clinical recommendations.
[19454449] Ann Oncol 20 Suppl 4(-): 182-4 (2009)
2009  
110
Cancer and thrombosis: implications of published guidelines for clinical practice.
[19561038] Ann Oncol 20(10): 1619-30 (2009)
2009  
111
2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group.
[19525362] Ann Oncol 20(9): 1459-71 (2009)
2010  
112
Imaging presentation of venous thrombosis in patients with cancer.
[20308518] AJR Am J Roentgenol 194(4): 1099-108 (2010)
2007  
113
Current diagnosis of venous thromboembolism in primary care: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.
[17261865] Ann Fam Med 5(1): 57-62 (2007)
2007  
114
Review of the evidence on diagnosis of deep venous thrombosis and pulmonary embolism.
[17261866] Ann Fam Med 5(1): 63-73 (2007)
2007  
115
Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians.
[17261867] Ann Fam Med 5(1): 74-80 (2007)
2003  
116
Antithrombotic therapy for the treatment of venous thromboembolism.
[14620791] Am J Manag Care 9(5 Suppl): S103-14; quiz S115-20 (2003)
2002  
117
ABC of antithrombotic therapy: Venous thromboembolism: treatment strategies.
[12399348] BMJ 325(7370): 948-50 (2002)
2002  
118
ABC of antithrombotic therapy: An overview of antithrombotic therapy.
[12364307] BMJ 325(7367): 762-5 (2002)
2004  
119
Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review.
[15383452] BMJ 329(7470): 821 (2004)
2007  
120
Preventing deep vein thrombosis in hospital inpatients.
[17641348] BMJ 335(7611): 147-51 (2007)
2006  
121
When can patients with acute deep vein thrombosis be allowed to get up and walk?
[17044314] Cleve Clin J Med 73(10): 893-4, 896 (2006)
2005  
122
Update in thrombosis: answers to perplexing questions.
[16231687] Cleve Clin J Med 72(10): 907-15 (2005)
2008  
123
Prevention of venous thromboembolism in the cancer surgery patient.
[18496913] Cleve Clin J Med 75 Suppl 3(-): S17-26 (2008)
2008  
124
Prevention of venous thromboembolism in the orthopedic surgery patient.
[18494224] Cleve Clin J Med 75 Suppl 3(-): S27-36 (2008)
2008  
125
Prevention of venous thromboembolism in the hospitalized medical patient.
[18494223] Cleve Clin J Med 75 Suppl 3(-): S7-16 (2008)
2008  
126
An overview of venous thromboembolism: impact, risks, and issues in prophylaxis.
[18494222] Cleve Clin J Med 75 Suppl 3(-): S3-6 (2008)
2009  
127
Prevention of venous thromboembolism after surgery.
[19880836] Cleve Clin J Med 76 Suppl 4(-): S45-52 (2009)
2003  
128
Rational use of D-dimer measurement to exclude acute venous thromboembolic disease.
[14601697] Mayo Clin Proc 78(11): 1385-91 (2003)
2002  
129
Upper-extremity deep vein thrombosis.
[12356644] Circulation 106(14): 1874-80 (2002)
2004  
130
Initial treatment of venous thromboembolism.
[15339875] Circulation 110(9 Suppl 1): I3-9 (2004)
2004  
131
Long-term management of patients after venous thromboembolism.
[15339876] Circulation 110(9 Suppl 1): I10-8 (2004)
2004  
132
New anticoagulants for treatment of venous thromboembolism.
[15339877] Circulation 110(9 Suppl 1): I19-26 (2004)
2004  
133
Invasive approaches to treatment of venous thromboembolism.
[15339878] Circulation 110(9 Suppl 1): I27-34 (2004)
2004  
134
Preventing venous thromboembolism in medical patients.
[15598642] Circulation 110(24 Suppl 1): IV13-9 (2004)
2004  
135
Prevention of recurrent idiopathic venous thromboembolism.
[15598644] Circulation 110(24 Suppl 1): IV20-4 (2004)
2004  
136
Comparing the costs, risks, and benefits of competing strategies for the primary prevention of venous thromboembolism.
[15598645] Circulation 110(24 Suppl 1): IV25-32 (2004)
2004  
137
Prevention of venous thromboembolism in surgical patients.
[15598646] Circulation 110(24 Suppl 1): IV4-12 (2004)
2003  
138
Risk factors for venous thromboembolism.
[12814980] Circulation 107(23 Suppl 1): I9-16 (2003)
2003  
139
Natural history of venous thromboembolism.
[12814982] Circulation 107(23 Suppl 1): I22-30 (2003)
2008  
140
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.
[18779442] Circulation 118(13): 1373-82 (2008)
2003  
141
Upper extremity deep venous thrombosis.
[12796173] Chest 123(6): 1953-6 (2003)
2011  
142
Atherosclerosis and thrombosis: insights from large animal models.
[21274431] J Biomed Biotechnol 2011(-): 907575 (2011)
2007  
143
Murine models of vascular thrombosis (Eitzman series).
[17600224] Arterioscler Thromb Vasc Biol 27(10): 2079-93 (2007)
2009  
144
Venous thromboembolism: risk factors for recurrence.
[19228602] Arterioscler Thromb Vasc Biol 29(3): 298-310 (2009)
2009  
145
New insights into cancer-associated thrombosis.
[19228604] Arterioscler Thromb Vasc Biol 29(3): 316-20 (2009)
2009  
146
Venous thrombosis in the antiphospholipid syndrome.
[19228605] Arterioscler Thromb Vasc Biol 29(3): 321-5 (2009)
2009  
147
2009  
148
2002  
149
The role of high density lipoproteins in thrombosis.
[12806041] ScientificWorldJournal 2(-): 89-95 (2002)
2010  
150
Tissue factor and thrombosis: The clot starts here.
[20539911] Thromb Haemost 104(3): 432-9 (2010)
2002  
151
Update of the management of venous thromboembolism.
[11963288] Rev Port Cardiol 21(2): 183-99 (2002)
2006  
152
How I treat venous thrombosis in children.
[16099882] Blood 107(1): 21-9 (2006)
2008  
153
How I treat rare venous thromboses.
[18805965] Blood 112(13): 4818-23 (2008)
2011  
154
Pathophysiology of thrombosis in myeloproliferative neoplasms.
[21282719] Haematologica 96(2): 183-6 (2011)
2009  
155
Platelet receptors and signaling in the dynamics of thrombus formation.
[19286885] Haematologica 94(5): 700-11 (2009)
2005  
156
Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review.
[15921382] Haematologica 90(5): 672-7 (2005)
2008  
157
Pharmacokinetics, efficacy, and safety of LMWHs in venous thrombosis and stroke in neonates, infants and children.
[17906688] Br J Pharmacol 153(6): 1120-7 (2008)
2005  
158
Minding the gaps to promote thrombus growth and stability.
[16322784] J Clin Invest 115(12): 3385-92 (2005)
2010  
159
Epidemiology and pathophysiology of cancer-associated thrombosis.
[20386546] Br J Cancer 102 Suppl 1(-): S2-9 (2010)
2010  
160
Antithrombotic therapy and survival in patients with malignant disease.
[20386547] Br J Cancer 102 Suppl 1(-): S24-9 (2010)
2010  
161
Treatment and secondary prevention of venous thromboembolism in cancer.
[20386545] Br J Cancer 102 Suppl 1(-): S17-23 (2010)
2004  
162
D-dimer testing for deep venous thrombosis: a metaanalysis.
[15142977] Clin Chem 50(7): 1136-47 (2004)
2006  
163
Protein Z and its role in venous and arterial thrombosis.
[16450754] Isr Med Assoc J 8(1): 53-5 (2006)
2005  
164
Venous thromboembolism: diagnosis and management of deep venous thrombosis.
[15865594] Med J Aust 182(9): 476-81 (2005)
2010  
165
Deep vein thrombosis--risks and diagnosis.
[20628659] Aust Fam Physician 39(6): 468-74 (2010)
2011  
166
The role of nanomedicine in the imaging and therapy of thrombosis.
[22026372] Nanomedicine (Lond) 6(8): 1291-3 (2011)
2004  
167
Hypercoagulability and venous thromboembolism: a review.
[15139558] WMJ 103(2): 41-9 (2004)
2002  
168
Plasma D-dimers in the diagnosis of venous thromboembolism.
[11926847] Arch Intern Med 162(7): 747-56 (2002)
2004  
169
Relationship between deep venous thrombosis and the postthrombotic syndrome.
[14718318] Arch Intern Med 164(1): 17-26 (2004)
2010  
170
Mechanisms of cell signaling by the scavenger receptor CD36: implications in atherosclerosis and thrombosis.
[20697562] Trans Am Clin Climatol Assoc 121(-): 206-20 (2010)
2003  
171
Principle mechanisms underlying venous thromboembolism: epidemiology, risk factors, pathophysiology and pathogenesis.
[12584387] Respiration 70(1): 7-30 (2003)
2010  
172
Do galectins play a role in venous thrombosis? a review.
[19959209] Thromb Res 125(5): 373-6 (2010)
2010  
173
P-selectin/ PSGL-1 inhibitors versus enoxaparin in the resolution of venous thrombosis: a meta-analysis.
[19962723] Thromb Res 125(4): e138-42 (2010)
2010  
174
Emerging roles of fibronectin in thrombosis.
[20116835] Thromb Res 125(4): 287-91 (2010)
2007  
175
Epidemiology and risk factors for venous thrombosis.
[17433897] Semin Hematol 44(2): 62-9 (2007)
2008  
176
Role of the PROS1 gene in thrombosis: lessons and controversies.
[19809585] Expert Rev Hematol 1(1): 9-12 (2008)
2009  
177
Inferior vena cava thrombosis in young adults--a review of two cases.
[19568450] Ulster Med J 78(2): 129-33 (2009)
2007  
178
Management of deep vein thrombosis.
[18091696] Int Angiol 26(4): 302-5 (2007)
2007  
179
The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis.
[18091697] Int Angiol 26(4): 306-11 (2007)
2006  
180
Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence).
[16763532] Int Angiol 25(2): 101-61 (2006)
2003  
181
"Pathophysiologic mapping" of venous thromboembolism: opportunities for radiolabeled peptides.
[14973421] Q J Nucl Med 47(4): 292-320 (2003)
2003  
182
When deep venous thrombosis fails to respond to therapy.
[12755253] J Am Board Fam Pract 16(3): 246-50 (2003)
2009  
183
Basic mechanisms and pathogenesis of venous thrombosis.
[19683659] Blood Rev 23(5): 225-9 (2009)
2007  
184
Catheter-related thrombosis: a critical review.
[18632480] Support Cancer Ther 4(3): 145-51 (2007)
2011  
185
Role of tissue factor in venous thrombosis.
[20690821] Annu Rev Physiol 73(-): 515-25 (2011)
2010  
186
Review of pharmacology and physiology in thrombolysis interventions.
[22550379] Semin Intervent Radiol 27(4): 374-83 (2010)
PMC   
187
Treatment of high-risk venous thrombosis patients using low-dose intraclot injections of recombinant tissue plasminogen activator and regional anticoagulation.
[23273695] J Vasc Interv Radiol 24(1):27-34.e1 (2013)
PMC   
188
Splenectomy is modifying the vascular remodeling of thrombosis.
[24584745] J Am Heart Assoc 3(1):e000772 (2014)
PMC   
189
D-dimer for the diagnosis of venous thromboembolism in children.
[19006230] Am J Hematol 84(1):62-3 (2009)
PMC   
190
Hokusai-VTE: Edoxaban for the treatment of venous thromboembolism.
[24749116] Glob Cardiol Sci Pract 2013(4):416-20 (2013)
PMC   
191
Non-invasive embolus trap using histotripsy-an acoustic parameter study.
[23415285] Ultrasound Med Biol 39(4):611-9 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Thrombosis (BASKET).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Thrombosis (BASKET).php on line 92